ZIOPHARM Oncology, Inc. (ZIOP) Posts Q2 Loss of 29c/Share
Tweet
Share
E-mailGet Alerts ZIOP Hot Sheet
Price: $0.87 --0%
Financial Fact:
General and administrative: 3.54M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Financial Fact:
General and administrative: 3.54M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) reported Q2 EPS of ($0.29), $0.03 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $200 thousand versus the consensus estimate of $150 thousand.
For earnings history and earnings-related data on ZIOPHARM Oncology, Inc. (ZIOP) click here.
For earnings history and earnings-related data on ZIOPHARM Oncology, Inc. (ZIOP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean (RCL) tops Q1 expectations, raises full-year earnings guidance
- Bristol-Myers Squibb (BMY) tops Q1 earnings, revenue estimates; FY guidance updated
- Pool Corp. (POOL) Misses Q1 EPS by 1c; beats on guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
